Search Results - "Munusamy, Shankar"

Refine Results
  1. 1

    Renoprotective mechanisms of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease by Ravindran, Sreenithya, Munusamy, Shankar

    Published in Journal of cellular physiology (01-02-2022)
    “…Sodium‐glucose co‐transporter 2 inhibitors (SGLT2‐Is) have emerged as a promising class of antidiabetic drugs with cardioprotective and renoprotective effects…”
    Get full text
    Journal Article
  2. 2

    Nephroprotective Effects of Metformin in Diabetic Nephropathy by Ravindran, Sreenithya, Kuruvilla, Vinitha, Wilbur, Kerry, Munusamy, Shankar

    Published in Journal of cellular physiology (01-04-2017)
    “…Metformin, a well‐known anti‐diabetic agent, is very effective in lowering blood glucose in patients with type 2 diabetes with minimal side‐effects. Metformin…”
    Get full text
    Journal Article
  3. 3

    Crosstalk Between Oxidative Stress and Endoplasmic Reticulum (ER) Stress in Endothelial Dysfunction and Aberrant Angiogenesis Associated With Diabetes: A Focus on the Protective Roles of Heme Oxygenase (HO)-1 by Maamoun, Hatem, Benameur, Tarek, Pintus, Gianfranco, Munusamy, Shankar, Agouni, Abdelali

    Published in Frontiers in physiology (11-02-2019)
    “…Type-2 diabetes prevalence is continuing to rise worldwide due to physical inactivity and obesity epidemic. Diabetes and fluctuations of blood sugar are…”
    Get full text
    Journal Article
  4. 4

    Metformin attenuates albumin‐induced alterations in renal tubular cells in vitro by Allouch, Soumaya, Munusamy, Shankar

    Published in Journal of cellular physiology (01-12-2017)
    “…Proteinuria (albuminuria) plays a crucial role in the etiology of chronic kidney disease (CKD) via alteration of multiple signaling pathways and cellular…”
    Get full text
    Journal Article
  5. 5

    Smart Nanocarriers for the Delivery of Nucleic Acid‐Based Therapeutics: A Comprehensive Review by Ramasamy, Thiruganesh, Munusamy, Shankar, Ruttala, Hima Bindu, Kim, Jong Oh

    Published in Biotechnology journal (01-02-2021)
    “…Nucleic acid‐based therapies are promising therapeutics for the treatment of several systemic disorders, and they offer an exciting opportunity to address…”
    Get full text
    Journal Article
  6. 6

    Sestrin2 as a Novel Biomarker and Therapeutic Target for Various Diseases by Gorin, Yves, Eid, Assaad, Eid, Ali H., Pasha, Mazhar, Munusamy, Shankar

    Published in Oxidative medicine and cellular longevity (01-01-2017)
    “…Sestrin2 (SESN2), a highly conserved stress-inducible metabolic protein, is known to repress reactive oxygen species (ROS) and provide cytoprotection against…”
    Get full text
    Journal Article
  7. 7

    Mitochondrial superoxide plays a crucial role in the development of mitochondrial dysfunction during high glucose exposure in rat renal proximal tubular cells by Munusamy, Shankar, MacMillan-Crow, Lee Ann

    Published in Free radical biology & medicine (15-04-2009)
    “…Diabetic nephropathy is the leading cause of end-stage renal disease in the United States. Despite several studies indicating a role for mitochondrial…”
    Get full text
    Journal Article
  8. 8

    Microparticles as Potential Mediators of High Glucose-Induced Renal Cell Injury by Ravindran, Sreenithya, Pasha, Mazhar, Agouni, Abdelali, Munusamy, Shankar

    Published in Biomolecules (Basel, Switzerland) (06-08-2019)
    “…Diabetic nephropathy (DN) is the most common cause of chronic kidney disease worldwide. Activation of signaling pathways such as the mammalian target of…”
    Get full text
    Journal Article
  9. 9

    Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges by ElGamal, Heba, Munusamy, Shankar

    Published in Protein and peptide letters (01-01-2017)
    “…Diabetic nephropathy (DN) is one of the most serious microvascular complications of diabetes mellitus and the leading cause of end stage renal disease. One of…”
    Get more information
    Journal Article
  10. 10

    Metformin Induces Different Responses in Clear Cell Renal Cell Carcinoma Caki Cell Lines by Pasha, Mazhar, Sivaraman, Siveen K, Frantz, Ronald, Agouni, Abdelali, Munusamy, Shankar

    Published in Biomolecules (Basel, Switzerland) (22-03-2019)
    “…Clear cell renal cell carcinoma (ccRCC) is the most common and lethal form of urological cancer diagnosed globally. Mutations of the von Hippel-Lindau…”
    Get full text
    Journal Article
  11. 11

    Protective effects of Empagliflozin against Transforming growth factor‐beta‐induced fibrosis in renal proximal tubular cells by Bayne, Sarah, Munusamy, Shankar

    Published in The FASEB journal (01-05-2022)
    “…Background Chronic kidney disease (CKD) is the condition where the kidneys are unable to filter and clean the blood of waste properly. Hypertension, obesity,…”
    Get full text
    Journal Article
  12. 12

    Alteration of renal respiratory Complex-III during experimental type-1 diabetes by Munusamy, Shankar, Saba, Hamida, Mitchell, Tanecia, Megyesi, Judit K, Brock, Robert W, Macmillan-Crow, Lee Ann

    Published in BMC endocrine disorders (23-01-2009)
    “…Diabetes has become the single most common cause for end-stage renal disease in the United States. It has been established that mitochondrial damage occurs…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Mnemonics Improve Pharmacy Students' Knowledge Retention, Clinical Application, and Exam Performance in a PharmD Pharmacology Course by Munusamy, Shankar, Koenigsfeld, Carrie, Torry, Ronald

    Published in The FASEB journal (01-05-2022)
    “…Background Students in healthcare professions taking pharmacology courses often feel challenged with learning and remembering crucial facts about medications,…”
    Get full text
    Journal Article
  15. 15

    Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics by Ramasamy, Thiruganesh, Ruttala, Hima Bindu, Munusamy, Shankar, Chakraborty, Nilay, Kim, Jong Oh

    Published in Journal of controlled release (01-12-2022)
    “…Cancer, infectious diseases, and metabolic and hereditary genetic disorders are a global health burden affecting millions of people, with contemporary…”
    Get full text
    Journal Article
  16. 16

    Metformin Protects Renal Tubular Cells Against Albumin‐Induced Alterations and Cellular Injury by Allouch, Soumaya, Munusamy, Shankar

    Published in The FASEB journal (01-04-2016)
    “…Abstract only Introduction Proteinuria (or increased albumin excretion), a hallmark of chronic kidney disease (CKD), plays a critical role in the development…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Renoprotective Effects of Low‐dose Metformin Treatment in a Mouse Model of Diabetic Kidney Disease by Munusamy, Shankar, Olstinske, Kayla, Karch, Christopher, Frantz, Ronald, Carnevale, Kevin

    Published in The FASEB journal (01-05-2021)
    “…Background Diabetes mellitus (DM) affects more than 30 million people in the United States. About one‐third of DM patients develop diabetic kidney disease…”
    Get full text
    Journal Article
  19. 19

    Myrtenal attenuates oxidative stress and inflammation in a rat model of streptozotocin-induced diabetes by Rathinam, Ayyasamy, Pari, Leelavinothan, Venkatesan, Manigandan, Munusamy, Shankar

    Published in Archives of physiology and biochemistry (02-01-2022)
    “…The present study was aimed to investigate the effect of myrtenal on diabetes-associated oxidative stress, lipid peroxidation (LPO), and inflammation using a…”
    Get full text
    Journal Article
  20. 20

    ANTI‐NEOPLASTIC EFFECTS OF METFORMIN AGAINST RENAL CLEAR CELL CARCINOMA by Munusamy, Shankar, Pasha, Mazhar, Agouni, Abdelali

    Published in The FASEB journal (01-04-2018)
    “…Background and Objectives Renal clear cell carcinoma (RCCC) is the most common and lethal form of urological cancer diagnosed globally. Mutation of Von‐Hippel…”
    Get full text
    Journal Article